Home business company profiles reviews & industry history since 1999

Zinzino Buys Uzesta's Asia Distributor Network and Assets in Deal Worth Up to $7.2 Million


GOTHENBURG, Sweden - November 11, 2026

Zinzino, the Swedish direct-selling company known for its at-home blood-test kits and omega-3 BalanceOil supplements, has bought the core assets of Uzesta Global LLC, a U.S.-based direct seller of health and wellness products whose business is concentrated in Asia, in a deal that could be worth as much as $7.2 million.

The transaction, announced November 11, is an asset purchase rather than a takeover of the company itself. Through its subsidiaries in Taiwan, Hong Kong and Thailand, Zinzino acquired the rights to Uzesta's distributor database and the customer records that go with it, along with Uzesta's inventory and intellectual property.

Uzesta sells its products through independent distributors in Taiwan, Malaysia, Hong Kong and Thailand, and Zinzino put the business's annual revenue at about $4 million.

Zinzino will pay $800,000 in cash when the deal closes, followed by a deferred payment of $400,000. On top of that, the agreement provides for additional payments tied to how the business sells after the purchase, which could reach $6 million under the best-case scenario. Zinzino said 91% of any such earnout will be paid in newly issued Zinzino shares, and that it is covering the cash portion out of its own reserves.

The company said it expects to fold Uzesta into its existing technology platform, marketing organization and regional offices in Kuala Lumpur and Taipei, and that running the business on that shared infrastructure should let it expand at low cost and gradually improve the acquired operation's profitability. It also pointed to growth from combining the two distributor networks and pairing its test-based product approach with Uzesta's product line.

Chief executive Dag Bergheim Pettersen framed the deal around personalized health products sold through direct sales. Uzesta co-founder Dan Zhu said he sees Uzesta's liposomal supplement technology as a natural complement to Zinzino's test-driven nutrition products and called the timing of the integration right.

The purchase is the latest in a string of acquisitions Zinzino has used to add distributors and enter new markets. The company bought VMA Life in 2020, Enhanzz in 2022, Xelliss in 2024 and Zurvita in 2025, and it has already added Sanki and ItWorks! this year.

The deal comes as Zinzino continues to post strong top-line growth. Earlier this fall the company said third-quarter revenue rose 18% to about SEK 928 million.

More Zinzino news